intervet
Español



  • Foreword
  • Management is key to disease control as tilapia producers intensify production
  • Studies demonstrate AQUAFLOR® (florfenicol) efficacy for control of
    S. iniae mortality in tilapia
  • AQUAFLOR® offers tilapia producers novel tool for fighting bacterial infections without prolonged withdrawal
  • Validated assay shows that AQUAFLOR® remains stable in floating or sinking pelleted feed for catfish, salmonids
  • Study shows that AQUAFLOR® reduces mortality from NHP-B infection in shrimp
  • AQUAVAC™ GARVETIL™ vaccine safely reduces streptococcosis mortality in tilapia
  • AQUAVAC™ ERGOSAN™ in rainbow trout initiates improved vaccine response, stress tolerance and weight
intervet
gallery








gallery
gallery
Foreword

Fish producers are moving toward intensified production in response to world demand for aquaculture products at the same time that consumer demand for safe, nutritious food is rising. Intense production can increase the risk for disease, however, and may require management changes.

Intervet/Schering-Plough Animal Health is committed to helping fish farmers meet these challenges. Toward this end, we hosted New Advances in Warmwater Aquaculture, a seminar held in San Antonio, Texas, in conjunction with the 2007 World Aquaculture Society meeting.

The daylong meeting, attended by fish farmers and specialists from Latin America, featured the latest scientific findings relative to managing disease in tilapia, shrimp and other warmwater species. The articles in this publication summarize key messages from those presentations.

Our thanks go to the speakers, who each gave meaningful, practical presentations and contributed to lively discussions with the audience during question and answer sessions.

Intervet/Schering-Plough Animal Health

Hank Behrend
Species Head
Global Aquatic Animal Health
Intervet/Schering-Plough Animal Health